IKZF1 and precursor B-cell acute lymphoblastic leukemia: Approximately two-thirds of pediatric B-ALL Ph+ cases have an IKZF1 deletion, but IKZF1 point mutations have been identified in up to 10% of IKZF1 deletion-negative B-ALL Ph+ cases.